| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |